Randy Guerra, MD

Global Medical Lead
Takeda Development Center Americas, Inc., Cambridge, MA, USA

Randy Guerra, MD - Global Medical Lead - Rare Hematology - Takeda. Randy Guerra is the Global Medical Director for Rare Hematology at Takeda in charge of the Hemophilia A portfolio. He's based in Cambridge, Massachussetts and has been with the company for 7 years in the Hemophilia A space.

Presentation(s):

• OC 27.2 - Clinical Outcomes Following Prophylaxis With Octocog Alfa in Patients With Moderate Hemophilia A: 8-Year Interim Read-out of the Real-world AHEAD International Study

  Sunday, July 10, 2022
  3:00 PM – 3:15 PM

• PB0664 - Demographic and Baseline Clinical Characteristics of Patients With Hemophilia A in China: Real-world Data From the AHEAD International Study

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0684 - Clinical Outcomes in Patients with Hemophilia A in Brazil: 3-years of Follow-up of the AHEAD International Study

  Monday, July 11, 2022
  6:30 PM – 7:30 PM